Results 111 to 120 of about 1,352 (181)

Progress of biological agents and CAR cell therapy in the treatment of common autoimmune diseases in children. [PDF]

Front Pediatr
Yin QL, Liu YQ, Zhang HM, Gao YD, Wang Y, Zhang WH.   +5 more
europepmc   +1 more source

14.2 Causes of early death in juvenile onset systemic lupus erythematosus (JSLE) [PDF]

Pediatric Rheumatology, 2008
Bader-Meunier, B, Klein, A, Aggarwal, A, Merino, R, Russo, R, Sztajnbok, F, Avcin, T, Knupp, S, Khubchandani, R, Ozen, S, Cimaz, R, Quartier, P   +11 more
openaire   +1 more source

Sexual dimorphism of early GPR183-dependent B cell responses in systemic lupus erythematosus. [PDF]

iScience
Matei DE, de Gruijter NM, Jenkins P, Radziszewska A, Peckham H, Jebson B, Karu K, Ciurtin C, Rosser EC.   +8 more
europepmc   +1 more source

The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus. [PDF]

Rheumatology (Oxford)
Md Yusof MY, Smith EMD, Lythgoe H, Psarras A, Armon K, Beresford MW, Cherry L, Corp N, Edwards CJ, Felix L, Flora K, Gilman R, Griffiths B, Gordon C, Isenberg D, Jordan N, Kinsey D, Kaul A, Laws PM, Lightstone L, Mallen CD, Marks SD, Maxwell N, McLaren Z, Moraitis E, Nash C, Pepper RJ, Pilkington C, Rostron H, Skeates J, Skeoch S, Tremarias D, van der Windt DA, Wincup C, Zoma A, Lanyon P, Vital EM, British Society for Rheumatology Guidelines Steering Group members.   +37 more
europepmc   +1 more source

Rethinking headache in juvenile systemic lupus erythematosus: the need for broader perspectives. [PDF]

Arq Neuropsiquiatr
Messina C.
europepmc   +1 more source

Juvenile-onset Systemic Lupus Erythematosus: Recent Advances in Pathogenesis and Treatment. [PDF]

Curr Rheumatol Rep
Natoli V, Charras A, Smith EM, Hedrich CM.   +3 more
europepmc   +1 more source

Exome sequencing enables molecular diagnosis in 10% of early-onset or familial systemic lupus erythematosus cases. [PDF]

EBioMedicine
Tusseau M, Khaldi-Plassart S, Labalme A, Mathieu AL, Riller Q, Molitor C, Simonet T, Viel S, Gaboriaud C, Thielens N, Heiser L, Chopin E, Rouvet I, Fabien N, Goncalves D, Fremeaux-Bacchi V, El-Sissy C, Pottier N, Larrue R, Ranchin B, Laurent A, Fouillet-Desjonqueres M, Jouret M, Mekinian A, Yamashita M, Morio T, Hachulla E, Melki I, Kone-Paut I, Ballot C, Reumaux H, Pillet P, Harambat J, Richez C, Richer O, Hatchuel Y, Louillet F, Lega JC, Durieu I, Welfringer-Morin A, Picard C, Messadi W, Sarrot-Reynauld F, Sanlaville D, Bader-Meunier B, Walzer T, Lesca G, Rieux-Laucat F, Belot A, GENIAL/LUMUGENE Collaborators.   +49 more
europepmc   +1 more source

Age-stratified risk factors and predictive models for progression to lupus nephritis in patients with systemic lupus erythematosus: a review. [PDF]

Front Immunol
Sun S, Li S, Chang X, Wu J.
europepmc   +1 more source

CVD-risk assessment in JSLE

, 2023
openaire   +1 more source

Impact of Juvenile Dermatomyositis on Growth, Puberty, Bone Mineral Density, and Body Composition in Children. [PDF]

Mediterr J Rheumatol
Sudhera N, Kaur H, Pandiarajan V, Singh S.   +3 more
europepmc   +1 more source